A Powerful Motivating VISION Compels FleurirABX to Action
The global crisis of bacterial infection and resistance, with its tragic untimely deaths, exorbitant hospitalization costs, and vast health and economic burdens to society, is finally controlled as innovative scientists, healthcare advocates, legislative champions, and insightful investors unite to bring new discoveries, flexible regulatory approaches, supportive legislation and economic incentives and ultimately to deliver safe and effective antibacterials to patients in dire need at prices that are affordable yet able to yield adequate profit to sustain their developers. Appropriate prescribing and good stewardship is achieved to further mitigate resistance development.
Our mission is to develop and market effective small-molecule antibacterial drugs that fulfill unmet need in the global crisis of bacterial resistance to antibiotics, and create significant value for FleurirABX, its partners, and investors.
